SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER

Manufacturer
SHISEIDO AMERICAS CORPORATION
Effective date
2026-01-06
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 01:31:36

Label at a glance#

ProductSHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER
Active ingredientTITANIUM DIOXIDE, OCTINOXATE, ENSULIZOLE
Label structure9 sections

Indications and uses

helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Dosage and administration

For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every two hours Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: limit time in the ...

Storage and handling

Protect this product in this container from excessive heat and direct sun.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredientsPurpose
ENSULIZOLE 1.0%Sunscreen
OCTINOXATE 3.9%Sunscreen
TITANIUM DIOXIDE 4.1%Sunscreen

Uses

INDICATIONS & USAGE SECTION

  • helps prevent sunburn
  • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use on damaged or broken skin

OTC - WHEN USING SECTION

When using this productkeep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

Stop use and ask a doctorif rash occurs.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For sunscreen use:

  • apply liberally 15 minutes before sun exposure
  • use a water resistant sunscreen if swimming or sweating
  • reapply at least every two hours
  • Sun Protection Measures.
    Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
    • limit time in the sun, especially from 10 a.m. – 2 p.m.
    • wear long-sleeve shirts, pants, hats, and sunglasses
  • children under 6 months: Ask a doctor

Inactive Ingredients

INACTIVE INGREDIENT SECTION

WATER∙DIMETHICONE∙BUTYLENE GLYCOL∙GLYCERIN∙ISOHEXADECANE∙SD ALCOHOL 40-B∙ZEA MAYS (CORN) STARCH∙PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE∙DIPHENYLSILOXY PHENYL TRIMETHICONE∙SILICA∙TRIISOSTEARIN∙DISTEARDIMONIUM HECTORITE∙CETYLETHYLHEXANOATE∙XYLITOL∙ERYTHRITOL∙TRIMETHYLSILOXYSILICATE∙TREHALOSE∙TOCOPHERYL ACETATE∙2-O-ETHYL ASCORBIC ACID∙PRUNUS SPECIOSA LEAF EXTRACT∙ANGELICA ACUTILOBA ROOT EXTRACT∙SCUTELLARIA BAICALENSIS ROOT EXTRACT∙CAMELLIA SINENSIS LEAF EXTRACT∙SODIUM ACETYLATED HYALURONATE∙ISODONIS JAPONICUS LEAF/STALK EXTRACT∙HYDROLYZED CONCHIOLIN PROTEIN∙ROSA ROXBURGHII FRUIT EXTRACT∙GOLD∙TRIETHANOLAMINE∙ISOSTEARIC ACID∙ALUMINUM HYDROXIDE∙STEARIC ACID∙DISODIUM EDTA∙ALCOHOL∙CALCIUM ALUMINUM BOROSILICATE∙BHT∙HYDROGEN DIMETHICONE∙TOCOPHEROL∙POLYSILICONE-2∙TRIETHOXYCAPRYLYLSILANE∙SODIUM CITRATE∙TIN OXIDE∙BARIUM SULFATE∙CITRIC ACID∙PHENOXYETHANOL∙FRAGRANCE∙TITANIUM DIOXIDE∙MICA∙IRON OXIDES

Other information

STORAGE AND HANDLING SECTION

Protect this product in this container from excessive heat and direct sun.

Questions or comments?

OTC - QUESTIONS SECTION

Call toll free 1-800-906-7503

PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SHISEIDO
GINZA TOKYO

FUTURE SOLUTION LX
Infinite Treatment Primer

SkingenecellEnmei

BROAD SPECTRUM
SPF 30
SUNSCREEN

40mL NET WT. 1.4 OZ.

PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton
PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5dbf91a8-ec29-4ffc-807c-e3bae7fb67b1Product name120201123
85bed648-23ca-4804-98e6-e36aee999cadProduct name120190717
80de93b4-8a94-428d-beb7-d644353ee70bProduct name120180424
eb4f7d5b-1286-40dc-b8bf-ad87ff51c688Product name120170522
db8eb201-78c7-4590-8a71-fac0a539bd8cProduct name120170404
141092be-5eb5-452e-9f69-2d350aa70a87Product name120161208

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58411-657-10SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER40 mL in 1 TUBEEMULSION403
58411-657-10SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER1 in 1 CARTONEMULSION13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 50 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
58411-65758411-657-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 48 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMERTITANIUM DIOXIDE, OCTINOXATE, AND ENSULIZOLESHISEIDO AMERICAS CORPORATIONff088b0c-27c9-4ea8-bf94-6261378c71902026-01-06WarningsExact identifier
ndc (package): 58411-657-10
ndc (product): 58411-657
ndc11 (package): 58411065710
spl id: 47b9be75-c9c2-b19a-e063-6294a90a3412
spl set id: ff088b0c-27c9-4ea8-bf94-6261378c7190

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.